Yamamoto Y, Ueyama T, Ito T, Tsuruo Y. Downregulation of growth hormone 1 gene in the cerebellum and prefrontal cortex of rats with depressive-like behavior. Physiol Genomics 47: 170-176, 2015. First published February 25, 2015 doi:10.1152/physiolgenomics.00119.2014.-Depressive-like behaviors in animals are usually assessed by standardized behavioral tests such as the forced swimming test (FST). However, individual variation in test performance may obscure group differences and thereby hinder the discovery of genes responsible for depression. Few reports have shown the influence of individual variability in identifying the genes associated with depressive-like behaviors. In this study, we conducted microarray analysis to identify genes differentially expressed in the prefrontal cortex (PFC) and cerebellum of rats stratified by FST immobility ratio (% immobility in 5 min) into a control group [immobility ratio: Ϫ1 to ϩ1 standard deviation (SD) from the mean] and a depressive group (immobility ratio: ϩ1 to ϩ2 SDs above the mean). Genes differentially expressed in both the cerebellum and PFC of the depressive group were Alas2, Gh1, Hbb, Hbe2, LOC689064, Mrps10, Mybpc, Olf6415, and Pfkb1. Ingenuity Pathway Analysis identified Gh1 as a hub gene in the networks of differentially expressed genes in both brain regions. This study indicates that the depressive-like behavior may be related to the decrease of Gh1 expression in the cerebellum and PFC. depression; growth hormone 1; forced swimming test; brain; microarray analysis; Ingenuity Pathway Analysis INDIVIDUAL DIFFERENCES IN physiological or behavioral performance indexes often conceal real group differences (e.g., treatment vs. control) in animal phenotype (16). To reduce variability due to individual phenotypic differences in each group, large numbers of animals are needed especially in behavioral tests (5, 32, 33) . Although this solution can be sufficient in behavioral tests measuring one or two factors, a substantial number of animals are needed to reduce the variability in high-throughput assays such as microarray analysis. In rodents, the predominant influence on individual differences in depressive-like behavior is social status, including dominant-submissive relationships (31). For example, submissive animals show depressive-like behaviors following one or more attacks by dominant littermates (18). While single housing can be used to solve this problem in an experimental setting, the resultant stress induced by social isolation can lead to aggression (2, 18). Thus, it is difficult to solve the problem of individual differences by housing and breeding methods alone.
INDIVIDUAL DIFFERENCES IN physiological or behavioral performance indexes often conceal real group differences (e.g., treatment vs. control) in animal phenotype (16) . To reduce variability due to individual phenotypic differences in each group, large numbers of animals are needed especially in behavioral tests (5, 32, 33) . Although this solution can be sufficient in behavioral tests measuring one or two factors, a substantial number of animals are needed to reduce the variability in high-throughput assays such as microarray analysis. In rodents, the predominant influence on individual differences in depressive-like behavior is social status, including dominant-submissive relationships (31) . For example, submissive animals show depressive-like behaviors following one or more attacks by dominant littermates (18) . While single housing can be used to solve this problem in an experimental setting, the resultant stress induced by social isolation can lead to aggression (2, 18) . Thus, it is difficult to solve the problem of individual differences by housing and breeding methods alone.
An alternative strategy to identify genes associated with a particular behavior is to analyze individual behavior in a cohort and to divide animals of a single population into at least two subgroups according to the scores for a specific behavior (i.e., high and low responders) by means of the median split or upper and lower quartiles, among others (23) . Employing the forced swimming test (FST) to evaluate the depressive-like behavior, we observed significant differences in the neurotransmitter concentrations between the lower and upper thirds of the distribution of immobility time (26) .
Microarrays and pathway analyses have been widely used to identify genes associated with a particular phenotype or disorder. These analyses allow for rapid screening and quantification of expression differences in various animal models and subsequent evaluation of the relationships between differentially expressed gene groups and biological functions. Positron emission tomography and functional magnetic resonance imaging (MRI) studies comparing regional neural activity between major depressive disorder (MDD) patients and healthy controls (2, 21) have identified the hippocampus, amygdala, prefrontal cortex (PFC), and hypothalamus (among others) as promising regions for probing gene expression patterns associated with the depressive phenotype in animal models (10, 33) . Indeed, several reports have demonstrated associations between depressive-like behaviors and changes in the expression of various genes in the amygdala, hypothalamus, hippocampus, and PFC (10, 13) . For example, blood flow, metabolism, and cortical volume are reduced in the PFC of MDD patients (13) . In addition, more recent evidence has implicated the cerebellum in depression. While it is well known that cerebellar neurons project to the primary motor cortex via the ventrolateral nucleus of the thalamus (28) , it has recently been suggested that the medial PFC is also a target of these cerebellar projections (20) . In fact, reduced cerebellar blood flow has been observed in MDD (4). Moreover, morphometric MRI studies of MDD patients have found volume reductions in various cerebellar regions, while resting-state functional MRI has revealed altered functional connectivity between the cerebellum and multiple cortical regions, including the PFC.
In this study, we conducted microarray analysis of regional gene expression patterns in two groups of Wistar rats defined from a single population according to FST immobility ratio [control: Ϫ1 to ϩ1 standard deviation (SD) from the mean, and a depressive group: ϩ 1 to ϩ 2 SD above the mean] to identify novel depression-associated genes in the PFC and cerebellum.
MATERIALS AND METHODS
Animals. The rats used in this study were the F3 progeny of two F2 male and female Wistar rats derived from the same founders. The offspring were weaned at 4 wk and housed in plastic rat cages (24.7 ϫ 40.9 ϫ 19.7 cm) with free access to tap water and laboratory animal chow (Oriental Yeast, Tokyo, Japan) under a 12 h light-dark cycle (lights on at 9:00) at 25 Ϯ 1°C and 50 -60% humidity. They were treated in accordance with the American Physiology Society Guiding Principles for the Care and Use of Vertebrate Animals in Research and Training. The experimental protocol was approved by the Animal Experiment Committee of Wakayama Medical University.
FST. Male rats (10 -11 wk old) were tested at 14:00 to evaluate inherent depressive-like behavior (25) . Rats were individually placed in a plastic cylinder (50 cm high and 30 cm in diameter) containing water 30 cm deep at 25°C. Behavior was recorded for 5 min. When a rat was observed floating in an upright position without moving, it was considered immobile. The immobility ratio was counted as the % time immobile over 5 min.
RNA preparation. To prepare RNA samples, 50 rats subjected to the FST 1 wk before were killed at 14:00 under isoflurane anesthesia. The brain was perfused with cold phosphate-buffered saline through the heart via a syringe and rapidly removed. Coronal brain sections (1 mm thick) were prepared on ice, with a brain slicer (Muromachi Kikai, Tokyo, Japan). The PFC was sliced 3.2-4.2 mm anterior to bregma, the hippocampus 2.8 -3.8 mm posterior to bregma, and the cerebellum 9.8 -10.8 mm posterior to bregma according to a stereotaxic atlas (23a). Total RNA was isolated immediately from these tissue samples with an RNeasy kit (Qiagen, Hilden, Germany).
Microarray and pathway analyses. An equal amount of RNA from four rats per group (defined by immobility ratio as described) was pooled. The quality of purified RNA was assessed with an Agilent 2100 Bioanalyzer with an RNA 6000 Nano Labchip kit (Agilent Technologies, Palo Alto, CA). Total RNA (400 ng per group) was first reverse-transcribed with a T7 sequence-conjugated oligo dT primer. At the same time, we used a One Color RNA Spike-In Kit (Agilent) for internal positive controls. Synthesis, amplification, and labeling of complementary RNA (cRNA) with Cy3 dye were performed according to the manufacturer's protocols. Prepared cRNA was added to a SurePrint G3 Rat Gene Expression 8 ϫ 60K Microarray Kit (Agilent). Hybridization was performed at 65°C for 17 h. After washing, fluorescence intensity was assayed with a scanner (G2565BA, Agilent). We quantified and analyzed the signal intensities by subtracting background fluorescence with Feature Extraction software (Agilent) and then normalized them with GeneSpring 12.0 software (Agilent). The complete datasets were deposited in the Gene Expression Omnibus database (accession number GSE63377).
Genes with expression levels that differed more than twofold (relative mRNA level) in the depression group compared with the control group were regarded as differentially expressed. We then used Ingenuity Pathway Analysis software (IPA, version: Fall 2013), which utilizes a database of known biological interactions among genes and proteins, to identify possible functional pathways associated with differentially expressed genes. We calculated the probability of a relationship between all differentially expressed genes and a possible biological function by Fisher's test (8, 11) , with P Ͻ 0.01 indicating a significant association. Networks containing 35 genes were generated based on known interactions between identified "focus genes" (the differentially expressed genes) and other genes in the database. In addition, IPA computes a score for each network according to the fit of the user's set of significant genes. The score, representing the Ϫlog (P value), indicates the likelihood of genes (including the focus genes) in a network from Ingenuity's knowledge base being found together due to random chance.
Quantitative real-time PCR. The expression levels of selected genes identified by microarray analysis were verified by quantitative real-time PCR. Total RNA (500 ng) for each group was obtained from rats not used for microarrays. First-strand cDNAs were generated using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA) and amplified by PCR with the KAPA SYBR FAST qPCR Kit (KAPA Biosystems, Wilmington, MA). Results were analyzed with CFX 2.1 software (Bio-Rad). The gene encoding ␤-actin (Actb) was used as the internal quantity control. The relative expression ratio of each mRNA (target/Actb) was normalized to that of the control group.
Statistical analysis. Means of continuous variables were compared by unpaired Student's t-test. For all comparisons, statistical significance was set at P Ͻ 0.05.
RESULTS

Individual variability in the FST. An increased immobility
ratio is a sign of depressive-like behavior in rodents (25) . To divide into normal 106 rats into three groups (control, depressive, and antidepressive group), we measured the immobility ratio in the FST and analyzed the distribution of immobility ratio of the 106 rats (a number sufficient for a distribution with statistical power of 0.9 when ␣ ϭ 0.05). The mean of immobility ratio was 28.2 Ϯ 6.8 (SD) %. The distribution was normal according to Kolmogorov-Smirnov (KS ϭ 0.07, P Ͼ 0.05, n ϭ 106) and the Jarque-Bera test [Jarque-Bera statistic (JB) ϭ 1.64, P Ͼ 0.05, n ϭ 106].
Differential gene in the cerebellum and PFC between control and depressive group rats. Rats were divided into three groups based on the distribution of individual immobility ratios: a control group with immobility ratio from Ϫ1 to ϩ1 SD from the mean (n ϭ 71), a depressive group with immobility ratio from ϩ1 to ϩ2 SD above the mean (n ϭ 18), and an antidepressive group with immobility ratio from Ϫ2 to Ϫ1 SD below the mean (n ϭ 12). There were fewer than four animals with immobility ratios under Ϫ2 SD (n ϭ 3) or over ϩ2 SD (n ϭ 2) from the mean. The average movement speed of rats in the FST when swimming was not correlated with immobility ratio according to the Pearson correlation coefficient (R 2 ϭ 0.064, P Ͼ 0.10, Fig. 1B ). Student's t-test also indicated no significant difference in the movement speed between the control (n ϭ 71) and depressive (n ϭ 18) groups (5.3 Ϯ 0.6 cm/s vs. 5.5 Ϯ 0.7 cm/s, t ϭ 0.53, df ϭ 87, P ϭ 0.63). Furthermore, the expression of BDNF, a known marker gene of depressive-like behavior, was 22% lower in the hippocampus of the depressive group compared with the control group (df ϭ 14, P Ͻ 0.05). Thus, we considered that the classification based on the distribution of immobility ratio reflected the degree of depressive-like behavior but not motor activity.
To examine the change of gene expression in cerebellum and PFC of the depressive group using microarray analysis, we selected the four rats in control or depressive group, and their RNA samples were pooled. Microarray analysis detected gene expression of 23,293 genes in cerebellum and 23,207 genes in PFC in at least one of the two groups. We defined the genes that changed more than twofold (relative mRNA level) compared with the control group as differentially expressed. By this criterion, expression of 137 genes differed significantly between the control and depressive groups in the PFC; 84 genes upregulated and 53 genes downregulated in the depressive group. In the cerebellum, 235 genes were differentially expressed, with 91 upregulated and 144 downregulated genes in the depressive group. In both brain regions, Hbe2, Hbb-b1, Hbb1, Hba1, LOC689064, Mybpc, Pfkfb1, Olf6415, and Alas2 were upregulated, and Gh1, the gene encoding growth hormone 1, and Mrps10 were downregulated.
We identified biological functions significantly related to these genes with IPA (P Ͻ 0.01). In the cerebellum, seven differentially expressed genes were associated with "proliferation of cells," while all other biological functions were anno- (Table 1) . No biological function was related to more than three differentially expressed genes in the PFC ( Table 2) . Analysis of biological functions revealed that only proliferation of cells was related to an increase in depressive-like behavior. We then investigated the gene groups related to depressive-like behavior using the network analysis application of IPA. Among the generated networks, two were significantly associated with the 235 differentially expressed genes in the cerebellum (P Ͻ 1.0E-10, Table 3 ). In network 2, Gh1 was a hub gene, and Gh1 expression was substantially downregulated in the depressive group (Fig. 2) . In the PFC, only one network was significantly associated with the 137 differentially expressed genes (P Ͻ 1.0E-10, Table 4 ). This network had several hub genes including Gh1 (Fig. 3) . Expression of Gh1 in rat cerebellum and PFC. To more accurately determine the magnitude of Gh1 differential expression between the control and depressive groups, we prepared RNA samples from other rats within each group and performed quantitative real-time PCR. Consistent with microarray analysis, expression of Gh1 was reduced to 12% of control in the cerebellum (df ϭ 6, P Ͻ 0.01, Fig. 4A ) and to 56% of control in the PFC (df ϭ 6, P Ͻ 0.05, Fig. 4B ).
DISCUSSION
To identify genes responsible for depressive-like behaviors, it is necessary to compare expression patterns between "depressive groups" exhibiting frequent or severe depressive-like behaviors and control groups under similar conditions. However, there is marked variation of depressive-like behaviors among individual animals in each group, which hampers the comparison of expression between control and depressive groups. In this study, we used an alternative strategy of comparing expression between control and depressive groups defined from the same population by their positions within the distribution of individual immobility ratios in the FST. Microarray analysis of control rats with scores around the means (Ϯ 1 SD) and rats with scores 1Ϫ2 SDs above the mean revealed a number of genes differentially expressed in the cerebellum and/or PFC. Network analysis indicated a functional network including Gh1 as a hub gene, while RT-PCR indicated that Gh1 expression was substantially decreased in the cerebellum and to a lesser extent in the PFC of the depressive group. Thus, Gh1 could be, at least partially, associated with the depressive-like behavior.
It is well known that individual variations in behavioral tests can obscure phenotypic differences (26) . Even in this rat population derived from the same two founders, there was substantial variability in immobility ratio. This variability was biased toward neither a depressive phenotype nor an antidepressive phenotype, as both the KS test (19) and JB test (15, 29) indicated normal distribution. To identify the genes responsible for this particular depressive-like behavior, we initially divided the 106 rats into five groups based on the immobility ratio distribution. There were too few rats (just two) in the most depressive group to evaluate statistically, so animals with immobility ratios of ϩ1 to ϩ2 SD above the mean were defined as the depressive group. The difference of behaviors in FST was not due to inherent variation in motor activity as there was no correlation between movement speed and immobility ratio. Furthermore, the expression of BDNF, a robust biomarker of depression (3), was dramatically lower in the hippocampus of the depressive group. Thus, classification based on the distribution of the immobility ratio would likely reflect the degree of depressive-like behavior in these rats. Depressive-like behavior is linked to neural aberrant activity in the hippocampus, amygdala, and hypothalamus, so these regions have been the focus of numerous animal studies on the pathophysiology of depression (10, 30) . Recently, the cerebellum has also been associated with emotional regulation through a cerebellum-PFC network (4, 24) . Although the PFC is strongly associated with depressive-like behavior (17), differentially expressed genes were 1.7 times more numerous in the cerebellum, suggesting that the cerebellum is a rich source of novel depression-related genes; this was consistent with findings of anatomic and functional imaging studies showing cerebellar atrophy and altered functional connectivity with limbic and cortical structures in MDD.
Little is known of the gene expression changes underlying these alterations in cerebellar anatomy and functional connectivity. In MDD patients, blood flow reductions have been observed in both PFC and cerebellum (2, 20) , suggesting at least some common dysregulated genes contributed to MDD pathogenesis. However, only 11 genes were up-or downregulated in both brain regions: Hbe2, Hbb-b1, Hbb1, Hba1, LOC689064, Mybpc, Pfkfb1, Olf6415, Alas2, Gh1, and Mrps10. The majority of the top 10 biological functions yielded by IPA (P Ͻ 0.01 of differential expression by random chance) were associated with fewer than five differentially expressed genes, while proliferation of cells was associated with seven genes (Ahr, Atm, Ccr1, Foxg1, Gh1, Prl, and Wnt7b). Neural progenitor cell proliferation is reduced in animals exhibiting greater depression-like behaviors (7), so proliferation of cells could be a biological function related to the depressive-like behavior. Although quantity of pituitary cells was the most significantly associated function, this region is not closely associated with the cerebellum functionally or anatomically. Thus, the seven genes included by proliferation of cells are the most notable genes related to the depressivelike behavior in the analysis of biological function.
The IPA yielded two networks from the 235 differentially expressed genes in the cerebellum and one network from the 137 differentially expressed genes in the PFC. Notably, Gh1 was a hub gene in both brain regions, suggesting a link between depressive-like behavior and downregulation of Gh1 in the cerebellum and prefrontal cortex. The expression of Gh1 was decreased in both regions, and real-time PCR revealed a substantial (88%) decrease in cerebellar expression and a 44% decrease in PFC expression. As a hub gene, this decreased Gh1 expression may alter the expression of numerous additional genes in the depressive group.
In the brain, Gh1 is expressed mainly in the pituitary and choroid plexus (14, 22) but also at lower levels in other brain regions of humans, rats, and chickens (1, 14, 22) . Decreased Gh1 expression in the cerebellum and PFC may be a key factor regulating depressive-like behavior because growth hormone is known to influence emotional behaviors (12) . Depressive-like behavior can be induced in rodents by stress (27) , and hippocampal Gh1 expression was upregulated by the stress of electric shock (6) . Thus, the change of Gh1 expression in the cerebellum and PFC could be correlated with the depressivelike behavior.
To identify genes associated with depressive-like behavior in rats, we utilized individual behavior variability. Specifically, we divided a single population into control and depressive groups by the distribution of individual immobility ratios in FST and subsequently compared gene expression patterns in cerebellum and PFC between these groups by microarray and pathway analysis. Gh1 was strongly downregulated in the depressive group, highlighting Gh1 in the cerebellum-PFC network as a potential regulator of depressive-like behavior.
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